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Trachomatous trichiasis (TT) caused by repeated or chronic ocular infection with Chlamydia 
trachomatis is the result of a pro-fibrotic ocular immune response. At the conjunctiva, the 
increased expression of both inflammatory (IL1B, TNF) and regulatory cytokines (IL10) have 
been associated with adverse clinical outcomes. We measured in vitro immune responses of 
peripheral blood to a number of chlamydial antigens. Peripheral blood effector cells (CD4, CD69, 
IFNγ, IL-10) and regulatory cells (CD4, CD25, FOXP3, CTLA4/GITR) were readily stimulated 
by C. trachomatis antigens but neither the magnitude (frequency or stimulation index) or the 
breadth and amount of cytokines produced in vitro [IL-5, IL-10, IL-12 (p70), IL-13, IFNγ, and TNFα] 
were significantly different between TT cases and their non-diseased controls. Interestingly 
we observed that CD4+ T cells account for <50% of the IFNγ positive cells induced following 
stimulation. Further investigation in individuals selected from communities where exposure to 
ocular infection with C. trachomatis is endemic indicated that CD3−CD56+ (classical natural killer 
cells) were a major early source of IFNγ production in response to C. trachomatis elementary 
body stimulation and that the magnitude of this response increased with age. Future efforts 
to unravel the contribution of the adaptive immune response to conjunctival fibrosis should 
focus on the early events following infection and the interaction with innate immune mediated 
mechanisms of inflammation in the conjunctiva.
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infection. Indeed work in mice has suggested that chlamydial vac-
cine induced immunity without pathology can be achieved and 
this is distinct from immunity induced by infection that results in 
pathology (Igietseme et al., 2009). However in naturally exposed 
populations only a minority develops the pathological sequelae of 
infection, suggesting that the immunological features of naturally 
immune individuals may be equally distinct.
In animal models of infection it is well established that CD4+ T 
helper type 1 (Th1) cells are essential for the clearance of primary 
chlamydial infection (Igietseme et al., 2009). In particular, IFNγ 
plays an important role in the clearance of chlamydial infection. 
In mice and in humans its production is associated with protec-
tion from re-infection (Wang et al., 1999; Cohen et al., 2005). 
However, uncontrolled inflammatory responses, in part driven by 
IFNγ production, result in pathology. Regulatory T cells (Tregs), 
induction of regulatory cytokines such as IL-10 or the activation 
of type 2 (Th2) responses counteract the inflammatory environ-
ment and contribute to restoring homeostasis (Yang et al., 1999; 
Wang et al., 2005). Conversely unchecked type 2 responses are 
frequently associated with chronic inflammation and infection 
(Wynn, 2004) and hampering Th2 responses have been implicated 
in chlamydial infections and induced disease (Holland et al., 1993, 
1996; Gondek et al., 2009). In addition some immune mediated 
fibrotic diseases, such as schistosomula induced hepatic fibrosis, 
IntroductIon
Chlamydia trachomatis is the leading infectious cause of blindness 
worldwide. Persistent infection or recurrent infection with C. tra-
chomatis, can stimulate a fibrotic immune response that leads to 
deposition of scar tissue on the upper tarsal conjunctiva and the 
development of a dry eye syndrome. The progressive development 
of scar tissue can lead to entropion and trachomatous trichiasis 
(TT), which if left untreated may result in damage to the cornea 
causing opacity, low vision, and blindness (Mabey et al., 2003). 
There are an estimated eight million individuals currently suffer-
ing from TT with about 1.3 million irreversibly blind as a result 
(Mariotti et al., 2009).
Chlamydia trachomatis is also the most common bacterial sexu-
ally transmitted infection. It is frequently asymptomatic, especially 
in women and can lead to sub-fertility, chronic pelvic inflammatory 
disease, ectopic pregnancy, and sterility (WHO, 2007). Although 
both ocular and genital chlamydial infections are treatable with 
antibiotics, persistent, and recurring infection is common. A 
licensed vaccine against C. trachomatis for use in the human popu-
lation is not yet available despite continued efforts since the 1960s. 
Recent developments (reviewed by Rockey et al., 2009) have yielded 
encouraging results in some animal models; however, the develop-
ment of an effective vaccine requires further understanding of the 
basic features of the human immune response to C. trachomatis 
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in rabbits with ocular HSV infection, cells in the conjunctiva, which 
expressed high levels of FOXP3, GITR, and CTLA4, were effectively 
able to suppress the effector function of HSV-specific CD4+ and 
CD8+ T cells (Nesburn et al., 2007).
In this study we compared the in vitro immune responses of 
individuals with TT and controls with normal eyes from trachoma 
endemic communities, since we expected that immune responses 
from these individuals would be the most polar. We investigated 
the immune responsiveness of several chlamydial antigens that 
had not previously been measured in individuals from trachoma 
endemic communities. Cytokine levels in supernatants from pro-
liferation assays were quantified for IL-5, IL-10, IL-12p70, IL-13, 
IFNγ, and TNFα. Immune responses were also assessed using flow 
cytometry, where cells were stained for IFNγ and IL-10, as well 
as Treg cell markers FOXP3, CTLA4, and GITR. To investigate 
which cells were the major sources of IFNγ, we further stained 
for markers that included CD8 and CD3−CD56+ cells in PBMC 
isolated from young and adult individuals from the same trachoma 
endemic environment.
MaterIals and Methods
study partIcIpants
Informed consent was obtained from all study participants. 
Participants were recruited from rural and semi-urban areas 
within the Western Region and the Lower river regions (LRR) of 
The Gambia. Trachoma was graded using the WHO simplified 
grading system by a single experienced field supervisor. Forty-two 
subjects with TT (more than one eyelash touching the globe of 
the eye) were identified. For each TT case an age, sex, and location 
matched control subject with normal eyes that was not a member 
of the same family was also recruited. Participants were age matched 
within 10 years. In a standardized manner, an ocular swab from 
the everted tarsal conjunctiva of each participant was collected 
into RNAlater® (Ambion Ltd) for the later isolation of proteins 
and nucleic acids. For the in vitro study of natural killer (NK) cell 
responsiveness, five healthy participants from three different age 
groups (2–5; 15–25; >35 years) from trachoma endemic commu-
nities in the West Kiang District of LRR were recruited. Historical 
exposure to ocular infection in these districts was expected to be 
high since structured surveys as part of a national trachoma control 
program identified this district as requiring mass drug treatment. As 
a result, these communities were treated with three annual rounds 
of oral azithromycin, completed in 2009 as per WHO guidelines 
for community control strategies. The joint Scientific and Ethics 
Committee of the Gambian government and the Medical Research 
Council Laboratories approved each study (applications L2006.10 
and SCC1201). In addition the ethics committee of the LSHTM also 
approved the studies. All study participants outside of community 
trachoma control programs were offered treatment according to 
national eye care program guidelines.
prolIferatIon assays
Venous blood (20 ml) was collected into tubes containing 300 units of 
sterile, preservative-free sodium heparin. After the removal of 2.5 ml 
of blood for whole blood cultures the PBMCs were isolated from the 
remaining blood by centrifugation over Lymphoprep (Axis-Shield 
Ltd, Kimbolton, UK) as described previously (Holland et al., 1996). 
are also  dominated by Th2-cytokine responses (Chiaramonte et al., 
2003). The pathogenic changes observed at the site of infection in 
chlamydial genital and ocular disease are also due to development 
of fibrotic tissue yet convincing evidence of a significant role for 
polar CD4+ Th2 responses or alternative macrophage activation are 
lacking (Holland et al., 2010; Natividad et al., 2010). Many groups 
have now demonstrated the important role of immunoregulatory 
subsets of CD4+ T cells in preventing immune damage during 
viral, bacterial, and parasitic infections, and specifically in persistent 
infections at mucosal surfaces (Maloy and Powrie, 2001; Belkaid 
and Tarbell, 2009) but these have not been extensively studied in 
human chlamydial disease.
One subset of CD4+ T cells that has key functions in immune 
homeostasis are Tregs (CD4+CD25+FOXP3+). The regulatory 
function of these natural and adaptive Tregs may be mediated by 
production of TGF-β and IL-10 or by cognate interaction (Hori 
et al., 2003; Fontenot et al., 2005). Antigen-specific IL-10 secreting 
type-1 T regulatory cells (T
R
1) which do not express FOXP3 have 
also been described in vivo following chronic antigenic stimulation 
(Vieira et al., 2004), and develop in parallel with Th1 cells in several 
chronic infectious diseases (McGuirk et al., 2002). Murine studies 
have established that FOXP3 + regulatory cells can secrete both IFNγ 
and IL-10 (Stock et al., 2004) and in humans regulatory function 
can also be exerted via perforin dependent lysis (Grossman et al., 
2004). Thus, although most work has focused on cells with a classic 
Treg phenotype (CD4+CD25+FOXP3+), cells from CD4+CD25−, 
CD8+, and NKT subsets can all exert regulatory function (Jiang 
and Chess, 2004). There is also evidence that CD4+ Th1 cells can 
exhibit self-regulatory properties and cytokine profiles, obviating 
the need to explain disease in terms of a separate regulatory class 
of T cells (Anderson et al., 2007; Jankovic et al., 2007).
We have previously demonstrated a relative Chlamydia-specific 
hypo-responsiveness associated with chronic ocular infection 
(Holland et al., 1993; Bailey et al., 1995), and described imbalances 
in antigen-specific secretion of both IL-10 and IFNγ in cultured 
peripheral blood mononuclear cell (PBMC) from scarred subjects 
(Holland et al., 1996). We have also found that IFNγ, IL-10, and 
perforin expression in the conjunctiva is associated with the clinical 
signs of active trachoma (Burton et al., 2004); that susceptibility to 
scarring sequelae is affected by haplotypic variation at the IL-10 
locus (Natividad et al., 2005, 2008), that contributes to variation in 
IL-10 expression; and that the expression of FOXP3 is up-regulated 
in individuals who have recently resolved ocular C. trachomatis 
infection (Faal et al., 2006).
In animal models of viral ocular infection, several groups have 
identified an important role for Tregs in modulating the severity of 
disease (Suvas et al., 2004; Nesburn et al., 2007). Aside from FOXP3, 
other potential makers of regulatory T cells have been identified 
in the search to phenotypically define Tregs. Most commonly the 
relative expression of the IL-7 receptor (CD127) is used as a fourth 
surface marker (Finney et al., 2010), the low expression of which is 
regarded as further evidence of Tregs. Two other common markers 
with demonstrated independent down regulatory properties are 
Cytotoxic T Lymphocyte Antigen 4 (CTLA4) and Glucocorticoid-
induced tumor necrosis factor-receptor related protein (GITR) 
both of which have been linked to the suppressive mechanism of 
Tregs (Zheng et al., 2004; Nocentini and Riccardi, 2005). Moreover, 
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were added to separate cultures. Abs used were as follows: CD69 
PE (CH/4; BD Pharmingen), CD56 PE (N901), CD56 APC (N901; 
both Beckman Coulter, Fullerton, CA, USA), CD56 PE-Cy7 (B159), 
CD3-PerCP (SK7), CD4 APC-Cy7 (RPA-T4), CD4 PE (RPA-T4), 
CD8 PE (SK1), CD3 PE-Texas Red (S4.1) CD107a (LAMP-1) biotin 
(H4A3; Caltag/Invitrogen), CD8 Pacific Blue (LT8; eBiosciences, 
San Diego, CA, USA), and IFNγ FITC (D9D10; Ab Serotec). For 
CD107a staining antibody and GolgiPlug™ were added to the 
cultures for the last 4 h of stimulation when they were washed 
and permeabilized. The remaining cocktail of antibodies was then 
added staining both surface and intracellular antigens. Samples 
were then examined using a Dakocytomation CyAn flow cytometer 
(Beckman Coulter, Fullerton, CA, USA) and the data collected using 
Summit FCS 4.3 software. Files were further analyzed using FlowJo 
(Treestar, OR, USA).
IsolatIon of dna froM ocular swabs
DNA was isolated from ocular swabs using Qiagen RNeasy micro 
kits and DNA mini kits as described elsewhere (Holland et al., 
2010). The presence of C. trachomatis was then tested using CT/
NG by Amplicor (Roche) as described previously (Holland et al., 
2010). Sample integrity and quality for each ocular swab was 
confirmed by performing PCR on genomic DNA using prim-
ers for human-specific hypervariable 1 (HV1) D-loop region 
mitochondrial DNA as described previously (Harding-Esch 
et al., 2009a).
serology
Plasma antibody titrations were performed using purified serovar 
A EBs immobilized on ELISA microtiter plates as described previ-
ously (Wang et al., 2009, 2010).
statIstIcal analysIs
Statistical analysis was performed using the statistical analysis 
tool in GraphPad Prism 5 software (GraphPad Software, Inc, 
La Jolla, CA, USA). A paired Student’s t-test was used for com-
bined data of cases and controls when compared to background 
controls. When comparing the response of matched cases and 
controls an adaptation of the Mann–Whitney distribution-free 
paired test was used (Wilcoxon signed rank). For the simultane-
ous comparison of three age groups we used a non-parametric 
ANOVA (GraphPad Prism) which is a omnibus Kruskal–Wallis 
test progressing to post hoc testing of simultaneous pairwise 
comparisons using Dunn’s Test if the overall P-value < 0.05. 
Both Kruskal–Wallis and Dunn’s Test are distribution-free tests 
of significance.
results
study partIcIpants
The basic study participant details from each section of the study 
are described in Table 1. Forty-two case–control pairs were used in 
the lymphocyte proliferation assays. Up to 17 of these case–control 
pairs were studied using FACS analysis and multiplex bead arrays 
for cytokines. Approximately 2/3 of the case–control pairs were 
from females (27/42) and the median age was 58 years. All ocular 
swabs for these samples were positive for human mitochondrial 
DNA and negative by CT/NG Amplicor for current ocular  infection 
Plasma was harvested by collection from above the PBMC layer and 
stored at −30°C for later use in enzyme-linked immunosorbent assays 
(ELISA) to estimate the anti-chlamydial antibody titer. PBMCs were 
co-incubated for 7 days with 5 μg/ml of each antigen (Pokeweed 
mitogen, PWM; Purified protein derivative, PPD) of Mycobacterium 
tuberculosis strain Rv37 and the following C. trachomatis antigens; 
Serovar A (strain SA1) elementary bodies (EBs), major outer mem-
brane protein (MOMP), Enolase, polymorphic outer membrane pro-
tein (Pmp) D, PmpG, outer membrane protein (Omp) 2. On day six, 
100 μl of culture supernatant was removed from each well without 
disturbing the cell pellet and 1 μCi/well 3H-thymidine added for the 
last 18 h of culture. The culture supernatant was frozen at −30°C until 
tested by multiplex bead array for cytokines. 3H-thymidine incorpo-
ration was estimated using liquid scintillation counting (Micro-beta, 
Wallac, Turku, Finland). Results were expressed as log
10
 stimulation 
indices (SI), which were calculated as described by Bennett and Riley 
(1992) using the geometric mean of the triplicate counts per minute 
(CPM) for the test antigen/CPM (geometric mean) of triplicate wells 
that only received cells and RPMI.
cytokIne detectIon
The triplicate wells of day six supernatants from microtiter plates 
were pooled and 25 μl used in a six-plex (IL-5, IL-10, IL-12p70, 
IL-13, IFNγ, and TNFα) cytokine assay (Bio-Rad, United Kingdom) 
according to the manufacturer’s instructions. The plates were then 
read using a Bio-plex instrument (Bio-Rad, UK). Unknown sam-
ples were quantified by reading standard curves prepared for each 
of the cytokines under study. Lower and upper limits of detection 
were dependent on assay performance. Any samples with cytokine 
levels that were outside of the working range of each assay were 
reported as under or over the detection limit and for the purposes 
of analysis were given a value equal to the minimum or maximum 
detectable level.
antIbody staInIng and facs analysIs
Five hundred microliters of whole blood was co-stimulated with 
10 μg/ml of FastImmune™ [CD28/CD49d co-stimulatory reagent 
(BD Biosciences)] and incubated with 5 μg/ml of whole Ct EB or 
Staphylococcus aureus Enterotoxin B (SEB) for 48 h. Cultures stimu-
lated with FastImmune™ alone served as controls. BD GolgiPlug™ 
(Brefeldin A; BD Biosciences) was added for the last 18 h of culture 
at 1 μg/ml. Cells were harvested by centrifugation followed by lysis 
of red blood cells and further washing in serum free RPMI by cen-
trifugation. When required, PBMC were permeabilized for intra-
cellular staining. The following antibodies were used: CD4-PerCP 
(SK3), CD25-FITC (M-A251), IFNγ-FITC (4S.B3), IL-10-PE (JES3-
19F1) and CTLA4-PE (BNI3) CD69-APC (FN50; BD Pharmingen), 
FOXP3-APC (PCH101; eBiosciences), and GITR-PE (110416; R&D 
Systems). Samples were then examined using a FACS Caliber flow 
cytometer (Becton, Dickinson and Company, NJ, USA) and the data 
collected using CellQuest-Pro. Files were further analyzed using 
FlowJo software (Treestar, OR, USA).
cell surface and Intracellular staInIng for nk cells
Surface and intracellular staining was performed as described previ-
ously (Horowitz et al., 2010a,b). Briefly 4 × 105 PBMC were incu-
bated for 24 h with 10 μg/ml EBs. As a positive control rIL-12/IL-18 
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IL-5 or IL-13 production. The levels of antigen-specific cytokine 
production are summarized in Figure 2. EB stimulated responses 
were significantly above background for IL-10, IFNγ, and TNFα 
in both TT cases and controls. However, these cytokine profiles 
did not correlate with disease status (Figure 2). Taken together 
the cytokine and proliferation data show that peripheral blood 
proliferative responses and cytokine production profiles are not 
significantly different between participants with and without TT.
cd4+cd25+foXp3+ cells are Increased followIng stIMulatIon 
wIth C. traChomatis antIgens
We investigated whether immune responses of TT patients differ 
in regulatory phenotypic markers when stimulated by chlamydial 
antigens compared to their respective controls. Whole blood from 17 
case–control pairs (n = 34) was stimulated with C. trachomatis EBs for 
48 h and stained with antibodies which in combination identify Tregs 
(CD4+CD25+FOXP3+). FOXP3+ cells were largely contained in the 
CD4+CD25+ population, where the CD25+ population was continu-
ous and no distinction was made between CD25hi+ and CD25lo+ cells. 
EBs were particularly effective at inducing Tregs, relative to those cells 
that received co-stimulation alone (Figure 3A). Figure 3B shows an 
example of the flow cytometry multilevel gating strategy used on 
each sample. CTLA4 and GITR were also used as additional surface 
markers of Treg activity. Stimulation with chlamydial EBs was effec-
tive in inducing the up-regulation of CTLA4 and GITR (Figure 3B). 
with C. trachomatis. Plasma anti-C. trachomatis antibody levels 
were not significantly different between the clinical groups and 
all sera were positive compared to plasma from immunologically 
naïve individuals.
lyMphocyte prolIferatIve responses to C. traChomatis 
antIgens
To determine whether the proliferative response of TT cases differed 
from that of the controls we studied the responses to chlamydial EBs 
and five recombinant antigens (Table 2). PWM was used as a positive 
control for the stimulation of T and B cells. We considered a SI > 2 
as a significant proliferative response. Enolase, PmpD, PmpG, and 
Omp2, induced a pathogen-specific proliferative response that was 
above background and comparable to proliferation induced by stim-
ulation with EBs. In general and as a trend, responses were higher 
in cases compared to controls; however, no statistically significant 
differences were found between TT cases and controls (Figure 1).
stIMulatIon of cytokIne responses by C. traChomatis 
antIgens
Day six supernatants from proliferation assays were collected and 
assessed for the presence of IL-5, IL-10, IL-12p70, IL-13, IFNγ, and 
TNFα cytokines. All antigens tested were able to elicit an IL-10, 
IL-12p70, IFNγ, and TNFα cytokine response that was significantly 
above background. Few antigens, however, were able to stimulate 
Table 1 | Study participant demographics and Ct antibody titers.
PBMC ProliFeraTioN SaMPleS
 Cases (n = 42) Controls (n = 42)
Age (range) in years 60 (30–85) 57 (30–80)
Sex
 Male 15 15
 Female 27 27
Anti-Ct (serovar A) antibody titer 1 × 104 (<1 × 103–2 × 104) 7.5 × 103  
  (<1 × 103–2 × 104)
CT/NG Amplicor 0 0
Flow CyToMeTry aNd Bio-Plex
 Cases (n = 17) Controls (n = 17)
Age (range) in years 58 (35–70) 54 (31–75)
Sex
 Male 6 6
 Female 11 11
Anti-Ct antibody titer (1/×; range) 1 × 104 (<1 × 103–2 × 104) 1 × 104 (<1 × 103–2 × 104)
CT/NG Amplicor (n =  no. positive) 0 0
NK PBMC Flow CyToMeTry
 <5 years (n = 5) <25 years (n = 5) >35 years (n = 5)
Age (range) 3 (2–5) 17 (16–25) 67 (37–72)
Sex
 Male 3 3 2
 Female 2 2 3
Anti-Ct (serovar A) antibody titer 1 × 103 1 × 103 (<1 × 103–2 × 104) 1 × 104 (<1 × 103–2 × 104)
No. with clinical signs 0 0 0
No. seropositive 2 5 5
CT/NG Amplicor (n =  no. positive) n.t. n.t. n.t.
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increase in CD69 expression and a higher frequency of IFNγ and 
IL-10 producing cells. Figure 4A shows the FACS analysis gat-
ing procedure used to examine IFNγ and IL-10 production from 
CD4+ T cells and total PBMC. Despite the induction of CD69 
on CD4+ cells and the production of IFNγ and IL-10, effector T 
cell responses were not significantly different between cases and 
controls (Figure 4C).
cd4 + cells are not the Major Ifnγ producIng cells In 
response to stIMulatIon wIth C. traChomatis eleMentary 
bodIes
To assess if CD4+ T cells encapsulated the observed increases in 
the percentage of CD69, IFNγ, and IL-10 in the total stimulated 
population of peripheral blood lymphocytes we examined the 
percentage of each of these in the CD4+ compartment and the 
total PBMC compartment. We found that on average less than 
half of the cells that were producing IFNγ, IL-10, or expressed 
However, when these phenotypic markers of regulatory activity were 
compared between TT cases and their controls, no statistical differ-
ence was found (Figure 3C). As a general trend CD4+CD25+FOXP3+ 
cells and CD4+GITR+ cells were higher in TT cases to all chlamydial 
antigens tested (additional data not shown). Similarly, no difference 
was detected in the frequency of CD4+FOXP3+ or CD4+CD25+ cells 
between cases and controls. Since no differences in regulatory cells 
were apparent we also used the CD4+CD25+FOXP3− population as 
an indicator of effector cell responses and found that the population 
frequencies of these cells were equivalent between cases and controls 
stimulated with EBs (Figure 3C).
actIvated lyMphocytes produce Ifnγ and Il-10 In response to 
C. traChomatis eleMentary bodIes
Whole blood was stimulated as previously described and stained 
for CD69, a marker of early activation, in addition to CD4, intra-
cellular IFNγ and IL-10. Stimulation with EBs showed a marked 
Table 2 | Summary of recombinant antigens used.
Serovar d 
locus-tag 
(NC000117)
Name antigen details 
(kda)
Serovar 
origin
dNa insert 
fragment 
size (bp)
Product 
size by 
SdS–
PaGe 
(kda)
Production 
of original 
expression 
clone
Fusion 
protein 
type
recombinant 
expression and 
purification
Publications 
(cellular 
responses 
only)
CT812 PmpD Polymorphic 
outer membrane 
protein 
(polymorphic 
family of 9 genes 
A–I; 160)
L2 2.024 kb 
(690–2714 
gene 
fragment)
74 Prof. Hill 
Gaston and 
Dr. Jane 
Goodall, 
University of 
Cambridge
His-tag pPET/ProBond® Goodall et al. 
(2001b)
CT681 MOMP Major outer 
membrane 
protein (40)
L1 1.6 kb 
(285–1182 
gene 
fragment)
33 Prof. Ian 
Clarke, 
University of 
Southampton
B-gal Induced 
insoluble 
inclusions 
purified by 
centrifugation 
resuspended in 
octylglucoside/
DTT
Holland et al. 
(1993)
CT871 PmpG Polymorphic 
outer membrane 
protein (107)
A 1.509 kb 
(127–1726 
gene 
fragment)
61 Dr. Mark 
Felton, 
LSHTM
His-tag pPET/ProBond® Felton (2002)
CT587 Enolase Phosphopyruvate 
hydratase 
(enolase family; 
45)
L2 1.274 kb 
(full length)
45 Prof. Hill 
Gaston and 
Dr. Jane 
Goodall, 
University of 
Cambridge
His-tag pPET/ProBond® Goodall et al. 
(2001b)
CT443 Omp2 Cysteine rich 
outer membrane 
protein (60)
L2 1.65 kb 
(700–2350 
gene 
fragment)
60 Prof. Hill 
Gaston and 
Dr. Jane 
Goodall, 
University of 
Cambridge
His-tag pPET/ProBond® Goodall et al. 
(2001a)
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dIscussIon
Both TT cases and controls had lymphoproliferative responses 
that were above background when stimulated with EBs, Enolase, 
PmpD, PmpG, and Omp2 antigens. Responses to some of these 
antigens have been investigated as putative vaccine candidates 
(Coler et al., 2009; Goodall et al., 2001a,b) and studied in human 
infection. More recently, a number of chlamydial antigens such 
as LcrE (CPn0324/CT089) and chlamydial protease-like activat-
ing factor (CPAF/CT858) have been proposed as potential vac-
cine candidates and their responsiveness has been tested in animals 
and humans (Olsen et al., 2006, 2007, 2010; Thorpe et al., 2007; 
Barker et al., 2008; Follmann et al., 2008). Although most of the 
TT study participants were able to elicit proliferative responses to 
the chlamydial antigens, the degree of proliferation was not sig-
nificantly different between individuals with severe scarring disease 
and controls without disease. As a general trend responses to each 
antigen were higher in cases with TT, in contrast to our previous 
findings (Holland et al., 1993, 1996). However, in previous stud-
ies higher proportions of individuals with trachomatous scarring 
were still infected with C. trachomatis and were at earlier stages 
of disease, where C. trachomatis driven fibrotic responses could 
still be progressing. We also previously found that serum antibody 
responses in those with trachomatous scarring were higher com-
pared to controls whereas in this cohort C. trachomatis serovar A 
antibody responses were equal between the groups. This suggested 
that both groups of individuals had experienced similar levels of 
exposure to ocular infection and that there had been little recent 
infection. This changing environment could explain why we did not 
detect any significant differences compared with our own previous 
findings (Harding-Esch et al., 2009b).
Although MOMP constitutes up to 60% of an EB it neverthe-
less contains a significant proportion of the total antigenic reper-
toire (Wang et al., 2010). It is the most abundant surface exposed 
protein of EBs, is highly conserved across C. trachomatis serovars 
containing a large number of T cell specific epitopes (Kim and 
DeMars, 2001; Nunes et al., 2010) and anti-MOMP antibodies 
have been shown to neutralize C. trachomatis in vitro (Cotter et al., 
1995). Because of these properties it has been widely studied as 
a putative vaccine candidate (Zhang et al., 1997). More recently 
native MOMP (nMOMP) has been used to immunize monkeys 
and successfully induced high titers of neutralizing antibodies that 
reduced the infectious ocular burden within the first 2 weeks of 
infection. Despite the promising results nMOMP immunization 
had no lasting effects on the course of clinical disease or burden 
and duration of infection (Kari et al., 2009). In our experiments 
MOMP induced only weak responses in the majority of individu-
als. Antibodies specific to PmpD have also been shown to neu-
tralize C. trachomatis in vitro regardless of serotype (Crane et al., 
2006), and Omp2 has been shown to be recognized by Chlamydia-
specific human CD8+ T cells (Gervassi et al., 2004). PmpG which 
is part of the outer membrane complex and may be involved in the 
invasion of the host cell by C. trachomatis was also tested. Each of 
these antigens induced responses but these were not significantly 
different between cases and controls. Thus far, with the exception 
of MOMP and hsp60, no other antigens have been evaluated by 
measuring cell mediated immune responses in individuals with 
trachoma. Skwor et al. (2010) have tested human tear fluid for 
CD69 were also CD4+ (Figure 4B). To establish which cells 
were responsible for IFNγ production we tested PBMC from 
individuals exposed to ocular infection but without current 
signs of trachoma. Five individuals were selected from three 
different age ranges. This strategy was chosen because we had 
demonstrated that endemic controls had significant responses 
to EBs above those observed with co-stimulation alone, but that 
these were not significantly different between case and control 
participants. Figure 5A shows representative FACS plots and 
flow diagrams of the gating and staining protocols used. There 
was some natural variation with age in the total percentage of 
NK cells (CD3−CD56+ cells) and of CD8+ T cells. The percent-
age of CD4+ T cells did not appear to vary with age (Figure 5B). 
We found that in the first 24 h of in vitro stimulation, EBs 
induced IFNγ in CD4+, CD8+, and NK cells. The percentage 
of IFNγ producing cells in response to stimulation with EB 
significantly increased with age and adults over 35 years of 
age demonstrated the highest levels. The percentage of CD4+ 
IFNγ+, although increased, did not appear to vary with age and 
the overall levels were approximately 4× lower. Interestingly, 
CD8+ IFNγ+ T cells were highest in the first two age groups 
though the overall levels were lower than those observed for 
NK (CD3−CD56+) cells (Figure 5C). Further confirmation 
that EB stimulation resulted in stimulation of NK cells that 
increased with age was seen by increasing levels of CD107a+ 
NK cells, whereas CD8+CD107a+ T cells decreased with age 
or were almost absent. As expected the CD4+ T cells expressed 
negligible levels of CD107a (Figure 5D). Figures 5C, D fur-
ther show that stimulation with EB leads to increases in the 
percentages of both IFNγ and CD107a expressing NK cells (up 
to 40% of NK cells express CD107a when stimulated by EB in 
adults over 35 years of age) compared to control cultures with 
culture medium alone and that in each case the difference and 
magnitude increases with age.
FiGure 1 | Trachomatous trichiasis cases do not differ in proliferative 
responses to Chlamydia trachomatis antigens compared to controls. 
PBMCs log10 stimulation index (test antigen c.p.m/non-stimulated c.p.m) were 
calculated after 6 days of stimulation with PWM or chlamydial antigens EBs, 
MOMP, Enolase, PmpD, PmpG, Omp2. Trichiasis cases (•) and disease free 
endemic controls (). Paired students t-test was performed on each group (up 
to 42 pairs). The dashed line represents stimulation index = 2. All responses 
above this dashed line were considered above background. Each antigen 
induced a statistically significant response above background. No statistical 
significance was detected between proliferative responses of the clinical 
groups to any chlamydial antigen. Analysis based on the proportion of 
responder (SI > 2) versus non-responder (SI < 2) also found that there were no 
differences evident between the clinical groups.
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disease (Wang et al., 1999). Another study found that when murine 
dendritic cells were infected with C. trachomatis, the subsequent 
production of IL-12 and TNFα correlated with containment of the 
bacteria (Knight et al., 1995). Furthermore, studies have shown that 
mice infected with C. muridarum that received CD11c+ CD8α+ cells 
had increased amounts of proinflammatory cytokines such as IFNγ, 
TNFα, and IL-12 and decreased production of the Th2 cytokines IL-4, 
IL-5, and IL-13, which correlated with protection against infection. 
Our results show that in peripheral blood of individuals exposed to 
C. trachomatis, most chlamydial antigens tested were able to produce 
above background levels of IL-10, IL-12, IFNγ, and TNFα cytokines 
antibody reactivity to a number of antigens (cHSP60, CPAF, and 
CT795) and found that IgG responses to CPAF were associated 
with TT cases and responses to all three antigens were elevated 
during inflammation, but it remains unclear how this might relate 
to cellular responses and requires further investigation.
Interleukin-10 and IFNγ have been extensively studied in mice 
and humans with respect to chlamydial infection and IL-10 has been 
found to be associated with the persistence of infection, while IFNγ 
has been linked to its resolution (reviewed in Yang, 2003). One study 
using IFNγ knockout mice infected with C. muridarum found that 
production of IL-5 was elevated and correlated with more severe 
FiGure 2 | Chlamydial antigens induce cytokine responses that are 
significantly above responses of cultures in culture medium alone, 
however, the levels of cytokine production are not statistically different 
between diseased and non-diseased individuals. Each plot represents IL-5, 
IL-10, IL-12p70, IL-13, IFNγ and TNFα production in response to stimulation 
with Ct EBs, MOMP, Enolase, PmpD, PmpG, and Omp2. Responses from TT 
cases and controls are depicted as shaded and non-shaded box and whisker 
plots respectively.
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after 6 days of culture. Only PmpD and Enolase were able to stimulate 
IL-5 and IL-13 cytokine responses respectively. However, there were 
no clear indications that any particular antigen or cytokine profile 
was significantly different between cases and controls. This suggests 
that a larger population study is required with follow-up and repeat 
testing, or that the methods employed in vitro are not sufficiently 
sensitive to detect differences in these particular cytokines.
Whilst the roles of IL-10 and IFNγ have been intensively stud-
ied in chlamydial disease, there has been little investigation of 
regulatory T cells in mediating the response to C. trachomatis. 
Our results show that Tregs (CD4+CD25+FOXP3+) and the 
co-stimulatory surface markers with inhibitory or regulatory 
functions (CTLA4 and GITR) are up-regulated in response to 
stimulation with chlamydial EBs. We also found higher levels 
of CD4+CD25+FOXP3+ and CD4+GITR+ T cells in TT cases 
compared to controls (although these differences were not sta-
tistically significant). Other authors have suggested that the 
CD4+CD25+FOXP3− can also represent an effector population 
(Burl et al., 2010); whilst these were increased over co-stimulation 
alone by stimulation with EB, the levels were not significantly 
different between TT cases and unaffected controls. Interestingly, 
we found that IFNγ produced in response to C. trachomatis EB 
was not exclusive to CD4+ lymphocytes, and the in vitro nature 
of the stimulation with non-viable EBs would not efficiently favor 
FiGure 3 | representative FaCS plots of whole blood cultured for 48 h 
with co-stimulatory molecules Cd28/Cd49d (a) or CD28/CD49d and 
chlamydial elementary bodies (B) are shown to demonstrate the gating 
strategy used to enumerate the percentage of Tregs. FOXP3+ cells were 
gated within the population of CD4+CD25+ cells. The CD25+ population was 
taken as continuous (CD25hi and CD25lo expressing cells were not 
differentiated). CD4+ effector cells were identified as the 
CD4+CD25+FOXP3− population. (C) Responses of trichiasis cases (n = 17) 
and endemic controls (n = 17) are represented as a stimulation ratio (i.e., 
percentage of CD4+CTLA4+ cells induced by EB stimulation/percentage  
of CD4+CTLA4+ induced by co-stimulation alone). Tregs and CD4+GITR+ 
cells were higher in trichiasis cases but there were no statistically significant 
differences between cases and controls in either regulatory or effector 
T cell populations.
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stimulation of CD8+ T cells. Given that <50% of the total IFNγ 
production appeared to be from CD4+ T cells, we investigated 
using flow cytometry which cells were responsible for the early 
IFNγ production. We found that even with a restricted sample 
size and therefore statistical power, CD3−CD56+ NK cells were a 
major source of very early IFNγ production (within the first 18 h 
of in vitro restimulation). Since the magnitude of this response 
increased with age and the frequency and duration of trachoma 
decrease with age (Bailey et al., 1999; Faal et al., 2006), it is pos-
sible that these cells play a significant role in ocular disease and 
infection. Such responses are not unique and are in line with those 
observed for responses following vaccination or as a result of 
protozoan or viral infection (Horowitz and Riley, 2010; Horowitz 
et al., 2010a,b; McCall et al., 2010). Interestingly, in subjects with 
active trachoma and infection, host gene transcriptional profiles 
in the conjunctiva suggest a previously unappreciated role for NK 
cells (Natividad et al., 2010). These initial in vitro experiments 
suggest that NK or NK-like cells are rapidly induced by EB and 
supports the suggestion that lymphocytes other than CD4+ T cells 
contribute a significant proportion of IFNγ in the periphery. EB 
FiGure 4 | Cd4+ cells are not the primary source of iFNγ following 
stimulation with eBs. (a) Representative FACS plots of whole blood cultured 
for 48 h with EBs and co-stimulatory CD28/CD49d demonstrate the gating 
strategy used to distinguish between total and CD4+ IFNγ producing cells, as 
well as total and CD4+ IL-10 producing cells. (B) Percentage of total IFNγ+, 
CD69+, and IL-10 producing cells is significantly higher than the percentage of 
CD4+ IFNγ+, CD4+CD69+, and CD4+IL-10+ cells in all trichiasis cases and 
controls (n = 34), indicating that CD4+ T cells are not the only source of IFNγ, 
IL-10, and activated cells. (C) Responses from trichiasis cases (n = 17) and 
controls (n = 17) represented as a stimulation ratio (as in Figure 3). The ratio of 
CD4+ activated (CD69+) or IFNγ+/IL-10+ cells are slightly higher in the control 
group but the difference is not significantly different.
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FiGure 5 | Cd3−Cd56+ natural killer (NK) cells are a major source of iFNγ 
in response to eB stimulation that increases with age. PBMC from healthy 
individuals ranging in age from 2 to 5 years (n = 5), 15–25 years (n = 5), and 
>35 years (n = 5) were stimulated for 24 h with EB. (a) Representative FACS 
plots demonstrate the gating strategy used to define populations of CD4+ and 
CD8+ T cells and NK cells. NK cells (CD3−CD56+) were gated from CD3+ T 
cells. The CD3+ T cells were then further sub-divided based on CD4+ or CD8+ 
expression. (B) Cell percentages in each age group demonstrate the natural 
variation of CD8+ T and NK cell levels, whereas CD4+ T cell levels do not 
appear to vary with age. (C) The percentage of NK cells producing IFNγ 
significantly increased with age, while the percentage of CD8+ IFNγ+ cells 
significantly decreased in the >35 years age group. The percentage of CD4+ 
IFNγ+ did not differ among the different age groups. (d) The percentage of 
CD107a+ NK cells significantly increased with age, whereas levels of CD107a 
expression in CD8+ T cells did not differ with age. CD4+ T cells expressed 
negligible levels of CD107a.
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